4/1
08:09 am
dare
Daré Bioscience, Inc. (NASDAQ: DARE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Low
Report
Daré Bioscience, Inc. (NASDAQ: DARE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
2/2
07:35 am
dare
Daré Bioscience, Inc. (NASDAQ: DARE) was downgraded by analysts at Dawson James from a "buy" rating to a "neutral" rating.
Low
Report
Daré Bioscience, Inc. (NASDAQ: DARE) was downgraded by analysts at Dawson James from a "buy" rating to a "neutral" rating.